Headlines & Global News | A New Novartis Heart Failure Drug Might Be A Blockbuster Forbes I try to avoid using words like “blockbuster” and “breakthrough” when writing about new drugs and treatments. I've been disappointed too many times. But, though they've been in short supply lately in cardiovascular medicine, sometimes there really are ... DMC recommends early closure of Novartis' study of LCZ696 for chronic heart ... Novartis to Seek Approval Earlier than Expected for Chronic Heart Failure ... Novartis' dual-action heart failure drug aces trial |
